Position in GSK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$353,205
-$18,499 QoQ
Shares Held
6,738
+0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#556
of 1,033 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VIAWEALTH, LLC holds $8,441,332 across 7 Drug Manufacturers - General names. GSK ranks #7 (4.2% of the industry book) .
All Filings in GSK
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $353,205 | 6,738 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $371,704 | 6,735 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $330,333 | 6,736 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $326,807 | 7,572 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $291,494 | 7,591 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $372,911 | 9,626 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $490,051 | 14,490 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $770,465 | 18,847 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $817,778 | 21,241 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $953,214 | 22,235 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $847,932 | 22,880 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,123,025 | 30,980 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,044,786 | 29,315 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $981,652 | 27,590 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $636,561 | 18,115 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||